Mason Street Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-365,764
| Closed | -$28.5M | – | 772 |
|
|
2020
Q4 | $28.5M | Sell |
365,764
-6,525
| -2% | -$499K | 0.48% | 25 |
|
|
2020
Q3 | $29.5M | Sell |
372,289
-5,359
| -1% | -$420K | 0.57% | 24 |
|
|
2020
Q2 | $27.9M | Sell |
377,648
-3,041
| -0.8% | -$229K | 0.56% | 28 |
|
|
2020
Q1 | $27.9M | Hold |
380,689
| – | – | 0.64% | 23 |
|
|
2019
Q4 | $33M | Sell |
380,689
-1,590
| -0.4% | -$131K | 0.63% | 21 |
|
|
2019
Q3 | $30.7M | Sell |
382,279
-2,535
| -0.7% | -$203K | 0.63% | 23 |
|
|
2019
Q2 | $30.8M | Sell |
384,814
-1,107
| -0.3% | -$84.8K | 0.64% | 24 |
|
|
2019
Q1 | $30.6M | Buy |
385,921
+1,708
| +0.4% | +$128K | 0.62% | 24 |
|
|
2018
Q4 | $28M | Sell |
384,213
-7,606
| -2% | -$537K | 0.68% | 23 |
|
|
2018
Q3 | $26.5M | Sell |
391,819
-3,756
| -0.9% | -$239K | 0.55% | 27 |
|
|
2018
Q2 | $22.9M | Buy |
395,575
+1,974
| +0.5% | +$111K | 0.5% | 31 |
|
|
2018
Q1 | $20.5M | Sell |
393,601
-5,672
| -1% | -$306K | 0.47% | 35 |
|
|
2017
Q4 | $21.4M | Buy |
399,273
+1,356
| +0.3% | +$75.2K | 0.48% | 37 |
|
|
2017
Q3 | $24.3M | Buy |
397,917
+85
| +0% | +$5.15K | 0.58% | 26 |
|
|
2017
Q2 | $24.3M | Buy |
397,832
+203
| +0.1% | +$12.4K | 0.61% | 27 |
|
|
2017
Q1 | $24.1M | Buy |
397,629
+2,361
| +0.6% | +$143K | 0.62% | 24 |
|
|
2016
Q4 | $22.2M | Buy |
395,268
+3,237
| +0.8% | +$189K | 0.6% | 25 |
|
|
2016
Q3 | $23.3M | Buy |
392,031
+1,299
| +0.3% | +$76K | 0.67% | 20 |
|
|
2016
Q2 | $21.5M | Buy |
390,732
+3,319
| +0.9% | +$177K | 0.63% | 21 |
|
|
2016
Q1 | $19.6M | Buy |
387,413
+4,950
| +1% | +$242K | 0.6% | 25 |
|
|
2015
Q4 | $19.3M | Buy |
382,463
+537
| +0.1% | +$27.1K | 0.6% | 25 |
|
|
2015
Q3 | $18M | Buy |
381,926
+676
| +0.2% | +$35.9K | 0.61% | 24 |
|
|
2015
Q2 | $20.7M | Sell |
381,250
-1,810
| -0.5% | -$102K | 0.63% | 23 |
|
|
2015
Q1 | $21M | Sell |
383,060
-1,221,023
| -76% | -$69.1M | 0.64% | 18 |
|
|
2014
Q4 | $86.9M | Buy |
1,604,083
+105,485
| +7% | +$5.88M | 0.61% | 14 |
|
|
2014
Q3 | $84.8M | Buy |
1,498,598
+338,308
| +29% | +$19M | 0.66% | 13 |
|
|
2014
Q2 | $64M | Sell |
1,160,290
-15,290
| -1% | -$834K | 0.5% | 24 |
|
|
2014
Q1 | $63.7M | Sell |
1,175,580
-37,875
| -3% | -$1.96M | 0.52% | 21 |
|
|
2013
Q4 | $58M | Buy |
1,213,455
+194,448
| +19% | +$8.89M | 0.47% | 27 |
|
|
2013
Q3 | $46.3M | Buy |
1,019,007
+52,444
| +5% | +$2.39M | 0.53% | 23 |
|
|
2013
Q2 | $42.8M | Buy |
+966,563
| New | +$43.2M | 0.47% | 37 |
|
Other funds holding MRK
Mason Street Advisors's MRK Position: Q1 2021 in Review
Mason Street Advisors sold out of Merck (MRK) in Q1 2021, closing a stake of 365,764 shares — an estimated $28.5M sold.
Mason Street Advisors first reported a position in MRK in Q2 2013 and held it in 31 quarters. The position peaked at $86.9M in Q4 2014. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.
- Mason Street Advisors reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 365,764 Merck shares in Q1 2021, an estimated $28.5M.
- Mason Street Advisors first reported a position in Merck in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Merck position peaked at $86.9M in Q4 2014.
- 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.